Preclinical Evaluation of M30 and M65 ELISAs as Biomarkers of Drug Induced Tumor Cell Death and Antitumor Activity

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-2136
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Preclinical Evaluation of Biomarkers Associated With Antitumor Activity of MELK Inhibitor

Oncotarget
Oncology
2016English

HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2014English

Membrane Transport on Tumor Cell and Antitumor Activity of Doxorubicin and Pirarubicin.

Drug Delivery System
Pharmaceutical Science
1998English

Antitumor Activity of 3-Ingenyl Angelate: Plasma Membrane and Mitochondrial Disruption and Necrotic Cell Death

Cancer Research
Cancer ResearchOncology
2004English

Preclinical Evaluation of Antitumor Activity of the Proteasome Inhibitor MLN2238 (Ixazomib) in Hepatocellular Carcinoma Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

MicroRNAs as Signaling Mediators and Biomarkers of Drug- And Chemical-Induced Liver Injury

Journal of Clinical Medicine
2015English

Erratum To: Preclinical Activity of Gefitinib in Non-Keratinizing Nasopharyngeal Carcinoma Cell Lines and Biomarkers of Response

Investigational New Drugs
OncologyPharmacology
2010English

Drug-Adapted Cancer Cell Lines as Preclinical Models of Acquired Resistance

2019English

Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis

Cancer Cell
Cancer ResearchOncologyCell Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy